Experts at a UNU-IIGH symposium urged stronger regulation of private sector influence to protect public health and ensure equity in global health governance.
The United Nations University International Institute for Global Health (UNU-IIGH) and Third World Network convened an international symposium in Kuala Lumpur to examine the increasing influence of private actors on health systems worldwide, particularly in low- and middle-income countries. Titled “Strengthening Global Health Governance: Defending the Public Interest and Holding Powerful Private Actors Accountable,” the event brought together more than 100 global health experts to discuss how commercial interests are shaping health outcomes and undermining public health goals.
Speakers raised urgent concerns about how corporate lobbying, monopolies in pharmaceuticals and food, and the financialisation of healthcare are threatening equitable access to essential services. Dr. Revati Phalkey, Director of UNU-IIGH, noted, “As funding cuts hit global health institutions, we are witnessing growing influence of commercial entities whose interests do not always align with public health priorities.”
WHO’s Dr. Monika Kosinska emphasized that while private actors play an important role in service delivery, their influence must be regulated to prevent harm. “Health is not only a matter of medical care but of governance,” she said. The symposium called for stronger accountability mechanisms, particularly around corporate tax practices that deprive countries of vital health funding. It also highlighted the need for systemic reforms to address the structural drivers of health inequality.
The event concluded with a united call for policies that centre public interest, equity, and transparency in global health governance.
